Covered recipient · General Payments record
SUSAN L KRAUS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$15,652.31
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $463.58 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $324.67 | 28 |
| Alkermes, Inc. | $48.47 | 2 |
| Teva Pharmaceuticals USA, Inc. | $26.98 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.51 | 1 |
| Neurocrine BioSciences, Inc. | $20.74 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.86 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485767 | CMS |
| ABBVIE INC. | $12.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485769 | CMS |
| ABBVIE INC. | $5.74 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485771 | CMS |
| ABBVIE INC. | $22.92 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485773 | CMS |
| ABBVIE INC. | $9.61 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485775 | CMS |
| ABBVIE INC. | $10.38 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485777 | CMS |
| ABBVIE INC. | $11.83 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485779 | CMS |
| ABBVIE INC. | $16.42 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485781 | CMS |
| ABBVIE INC. | $26.77 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485783 | CMS |
| ABBVIE INC. | $12.48 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485785 | CMS |
| ABBVIE INC. | $5.81 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485787 | CMS |
| ABBVIE INC. | $5.26 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485789 | CMS |
| ABBVIE INC. | $4.24 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485791 | CMS |
| ABBVIE INC. | $7.91 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485793 | CMS |
| ABBVIE INC. | $31.94 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485795 | CMS |
| ABBVIE INC. | $5.67 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485797 | CMS |
| ABBVIE INC. | $8.26 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485799 | CMS |
| ABBVIE INC. | $25.56 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485801 | CMS |
| ABBVIE INC. | $6.17 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485803 | CMS |
| ABBVIE INC. | $6.15 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485805 | CMS |
| ABBVIE INC. | $4.48 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485807 | CMS |
| ABBVIE INC. | $5.68 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485809 | CMS |
| ABBVIE INC. | $22.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485811 | CMS |
| ABBVIE INC. | $6.33 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485813 | CMS |
| ABBVIE INC. | $5.29 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485815 | CMS |
| ABBVIE INC. | $19.44 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485817 | CMS |
| ABBVIE INC. | $13.31 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485819 | CMS |
| ABBVIE INC. | $8.57 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107485821 | CMS |
| Alkermes, Inc. | $26.94 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120535751 | CMS |
| Alkermes, Inc. | $21.53 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120535753 | CMS |
| Neurocrine Biosciences, Inc. | $20.74 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150976047 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.21 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119116011 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.51 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137776879 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.53 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151626556 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.45 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151626618 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.